Epigenetic inactivation of the tumor suppressor IRX1 occurs frequently in lung sdenocarcinoma and its silencing is sssociated with impaired prognosis

Iroquois homeobox (IRX) encodes members of homeodomain containing genes which are involved in development and differentiation. Since it has been reported that the IRX1 gene is localized in a lung cancer susceptibility locus, the epigenetic regulation and function of IRX1 was investigated in lung car...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Küster, Miriam M. (VerfasserIn) , Schneider, Marc (VerfasserIn) , Richter, Antje M. (VerfasserIn) , Richtmann, Sarah (VerfasserIn) , Winter, Hauke (VerfasserIn) , Kriegsmann, Mark (VerfasserIn) , Pullamsetti, Soni S. (VerfasserIn) , Stiewe, Thorsten (VerfasserIn) , Savai, Rajkumar (VerfasserIn) , Muley, Thomas (VerfasserIn) , Dammann, Reinhard H. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 26 November 2020
In: Cancers
Year: 2020, Jahrgang: 12, Heft: 12, Pages: 1-19
ISSN:2072-6694
DOI:10.3390/cancers12123528
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers12123528
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/12/12/3528
Volltext
Verfasserangaben:Miriam M. Küster, Marc A. Schneider, Antje M. Richter, Sarah Richtmann, Hauke Winter, Mark Kriegsmann, Soni S. Pullamsetti, Thorsten Stiewe, Rajkumar Savai, Thomas Muley and Reinhard H. Dammann

MARC

LEADER 00000caa a2200000 c 4500
001 1788677218
003 DE-627
005 20220820123533.0
007 cr uuu---uuuuu
008 220207s2020 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers12123528  |2 doi 
035 |a (DE-627)1788677218 
035 |a (DE-599)KXP1788677218 
035 |a (OCoLC)1341441475 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Küster, Miriam M.  |e VerfasserIn  |0 (DE-588)1251340997  |0 (DE-627)178888079X  |4 aut 
245 1 0 |a Epigenetic inactivation of the tumor suppressor IRX1 occurs frequently in lung sdenocarcinoma and its silencing is sssociated with impaired prognosis  |c Miriam M. Küster, Marc A. Schneider, Antje M. Richter, Sarah Richtmann, Hauke Winter, Mark Kriegsmann, Soni S. Pullamsetti, Thorsten Stiewe, Rajkumar Savai, Thomas Muley and Reinhard H. Dammann 
246 3 0 |a one 
264 1 |c 26 November 2020 
300 |a 19 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.02.2022 
520 |a Iroquois homeobox (IRX) encodes members of homeodomain containing genes which are involved in development and differentiation. Since it has been reported that the IRX1 gene is localized in a lung cancer susceptibility locus, the epigenetic regulation and function of IRX1 was investigated in lung carcinogenesis. We observed frequent hypermethylation of the IRX1 promoter in non-small cell lung cancer (NSCLC) compared to small cell lung cancer (SCLC). Aberrant IRX1 methylation was significantly correlated with reduced IRX1 expression. In normal lung samples, the IRX1 promoter showed lower median DNA methylation levels (<10%) compared to primary adenocarcinoma (ADC, 22%) and squamous cell carcinoma (SQCC, 14%). A significant hypermethylation and downregulation of IRX1 was detected in ADC and SQCC compared to matching normal lung samples (p < 0.0001). Low IRX1 expression was significantly correlated with impaired prognosis of ADC patients (p = 0.001). Reduced survival probability was also associated with higher IRX1 promoter methylation (p = 0.02). Inhibition of DNA methyltransferase (DNMT) activity reactivated IRX1 expression in human lung cancer cell lines. Induced DNMT3A and EZH2 expression was correlated with downregulation of IRX1. On the cellular level, IRX1 exhibits nuclear localization and expression of IRX1 induced fragmented nuclei in cancer cells. Localization of IRX1 and induction of aberrant nuclei were dependent on the presence of the homeobox of IRX1. By data mining, we showed that IRX1 is negatively correlated with oncogenic pathways and IRX1 expression induces the proapoptotic regulator BAX. In conclusion, we report that IRX1 expression is significantly associated with improved survival probability of ADC patients. IRX1 hypermethylation may serve as molecular biomarker for ADC diagnosis and prognosis. Our data suggest that IRX1 acts as an epigenetically regulated tumor suppressor in the pathogenesis of lung cancer. 
650 4 |a adenocarcinoma 
650 4 |a apoptosis 
650 4 |a DNA methylation 
650 4 |a epigenetic 
650 4 |a homeobox 
650 4 |a IRX 
650 4 |a lung cancer 
650 4 |a tumor suppressor 
700 1 |a Schneider, Marc  |d 1982-  |e VerfasserIn  |0 (DE-588)140634401  |0 (DE-627)620239948  |0 (DE-576)319208095  |4 aut 
700 1 |a Richter, Antje M.  |e VerfasserIn  |4 aut 
700 1 |a Richtmann, Sarah  |d 1993-  |e VerfasserIn  |0 (DE-588)1193100828  |0 (DE-627)1671662024  |4 aut 
700 1 |a Winter, Hauke  |e VerfasserIn  |0 (DE-588)1162076038  |0 (DE-627)1025509773  |0 (DE-576)176791531  |4 aut 
700 1 |a Kriegsmann, Mark  |d 1987-  |e VerfasserIn  |0 (DE-588)103740324X  |0 (DE-627)755668782  |0 (DE-576)39141870X  |4 aut 
700 1 |a Pullamsetti, Soni S.  |e VerfasserIn  |4 aut 
700 1 |a Stiewe, Thorsten  |e VerfasserIn  |4 aut 
700 1 |a Savai, Rajkumar  |e VerfasserIn  |4 aut 
700 1 |a Muley, Thomas  |e VerfasserIn  |0 (DE-588)1056885432  |0 (DE-627)794179169  |0 (DE-576)16759284X  |4 aut 
700 1 |a Dammann, Reinhard H.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 12(2020), 12, Artikel-ID 3528, Seite 1-19  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Epigenetic inactivation of the tumor suppressor IRX1 occurs frequently in lung sdenocarcinoma and its silencing is sssociated with impaired prognosis 
773 1 8 |g volume:12  |g year:2020  |g number:12  |g elocationid:3528  |g pages:1-19  |g extent:19  |a Epigenetic inactivation of the tumor suppressor IRX1 occurs frequently in lung sdenocarcinoma and its silencing is sssociated with impaired prognosis 
856 4 0 |u https://doi.org/10.3390/cancers12123528  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/12/12/3528  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220207 
993 |a Article 
994 |a 2020 
998 |g 1193100828  |a Richtmann, Sarah  |m 1193100828:Richtmann, Sarah  |d 910000  |d 950000  |d 950900  |e 910000PR1193100828  |e 950000PR1193100828  |e 950900PR1193100828  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 4 
998 |g 1056885432  |a Muley, Thomas  |m 1056885432:Muley, Thomas  |d 50000  |d 910000  |d 950000  |d 950900  |e 50000PM1056885432  |e 910000PM1056885432  |e 950000PM1056885432  |e 950900PM1056885432  |k 0/50000/  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 10 
998 |g 103740324X  |a Kriegsmann, Mark  |m 103740324X:Kriegsmann, Mark  |d 910000  |d 912000  |d 50000  |e 910000PK103740324X  |e 912000PK103740324X  |e 50000PK103740324X  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 6 
998 |g 1162076038  |a Winter, Hauke  |m 1162076038:Winter, Hauke  |d 50000  |d 910000  |d 950000  |d 950900  |e 50000PW1162076038  |e 910000PW1162076038  |e 950000PW1162076038  |e 950900PW1162076038  |k 0/50000/  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 5 
998 |g 140634401  |a Schneider, Marc  |m 140634401:Schneider, Marc  |d 50000  |d 910000  |d 950000  |d 950900  |e 50000PS140634401  |e 910000PS140634401  |e 950000PS140634401  |e 950900PS140634401  |k 0/50000/  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 2 
999 |a KXP-PPN1788677218  |e 4052118510 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Miriam M.","display":"Küster, Miriam M.","family":"Küster","role":"aut"},{"family":"Schneider","role":"aut","display":"Schneider, Marc","given":"Marc"},{"role":"aut","family":"Richter","given":"Antje M.","display":"Richter, Antje M."},{"family":"Richtmann","role":"aut","given":"Sarah","display":"Richtmann, Sarah"},{"given":"Hauke","display":"Winter, Hauke","family":"Winter","role":"aut"},{"given":"Mark","display":"Kriegsmann, Mark","family":"Kriegsmann","role":"aut"},{"family":"Pullamsetti","role":"aut","given":"Soni S.","display":"Pullamsetti, Soni S."},{"given":"Thorsten","display":"Stiewe, Thorsten","role":"aut","family":"Stiewe"},{"family":"Savai","role":"aut","display":"Savai, Rajkumar","given":"Rajkumar"},{"given":"Thomas","display":"Muley, Thomas","role":"aut","family":"Muley"},{"given":"Reinhard H.","display":"Dammann, Reinhard H.","role":"aut","family":"Dammann"}],"recId":"1788677218","note":["Gesehen am 07.02.2022"],"language":["eng"],"name":{"displayForm":["Miriam M. Küster, Marc A. Schneider, Antje M. Richter, Sarah Richtmann, Hauke Winter, Mark Kriegsmann, Soni S. Pullamsetti, Thorsten Stiewe, Rajkumar Savai, Thomas Muley and Reinhard H. Dammann"]},"relHost":[{"disp":"Epigenetic inactivation of the tumor suppressor IRX1 occurs frequently in lung sdenocarcinoma and its silencing is sssociated with impaired prognosisCancers","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 27.05.2020"],"pubHistory":["1.2009 -"],"part":{"extent":"19","pages":"1-19","issue":"12","text":"12(2020), 12, Artikel-ID 3528, Seite 1-19","volume":"12","year":"2020"},"language":["eng"],"origin":[{"publisherPlace":"Basel","dateIssuedKey":"2009","dateIssuedDisp":"2009-","publisher":"MDPI"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["2072-6694"],"eki":["614095670"],"zdb":["2527080-1"]},"title":[{"title_sort":"Cancers","title":"Cancers"}],"recId":"614095670","name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]}}],"origin":[{"dateIssuedDisp":"26 November 2020","dateIssuedKey":"2020"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Epigenetic inactivation of the tumor suppressor IRX1 occurs frequently in lung sdenocarcinoma and its silencing is sssociated with impaired prognosis","title":"Epigenetic inactivation of the tumor suppressor IRX1 occurs frequently in lung sdenocarcinoma and its silencing is sssociated with impaired prognosis"}],"id":{"eki":["1788677218"],"doi":["10.3390/cancers12123528"]},"physDesc":[{"extent":"19 S."}]} 
SRT |a KUESTERMIREPIGENETIC2620